Evaluation of KRAS let-7 lcs6 Polymorphism in Korean Populations by Pyrosequencing
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
A single nucleotide polymorphism (SNP) in the 3′-untranslated region of the KRAS oncogene (rs61764370)was recently reported to act as a genetic marker for increased risk of developing human cancers. The frequency of the variant allele is 5.8% in world population, however, there is no study in Korean population with large cases. In present study, we evaluated the KRAS let-7 lcs6 SNP in Korean population for the first time. Genotyping was performed in 178 randomized subjects. DNA was extracted and SNP was evaluated by using PCR and pyrosequencing to identify the T or G allele of the KRAS let-7 lcs6 SNP. As a result, only T allele was found in all subjects and quantitative sequencing result showed that the proportion of G allele was extremely low. This study confirmed that KRAS let-7 lcs6 have only one allele system in Korean population by sensitive and quantitative pyrosequencing for the first time. Its clinical significance should be studied further.
Abstract
A single nucleotide polymorphism (SNP) in the 3′-untranslated region of the KRAS oncogene (rs61764370)was recently reported to act as a genetic marker for increased risk of developing human cancers. The frequency of the variant allele is 5.8% in world population, however, there is no study in Korean population with large cases. In present study, we evaluated the KRAS let-7 lcs6 SNP in Korean population for the first time. Genotyping was performed in 178 randomized subjects. DNA was extracted and SNP was evaluated by using PCR and pyrosequencing to identify the T or G allele of the KRAS let-7 lcs6 SNP. As a result, only T allele was found in all subjects and quantitative sequencing result showed that the proportion of G allele was extremely low. This study confirmed that KRAS let-7 lcs6 have only one allele system in Korean population by sensitive and quantitative pyrosequencing for the first time. Its clinical significance should be studied further.
참고문헌 (23)
- Ahmadian A, "Pyrosequencing: history, biochemistry and future", Clin Chim Acta, 363, pp.83~94 (2006)
- Calin GA, "Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers", Proc Natl Acad Sci USA, 101, pp.2999~3004 (2004)
- Carletti MZ, "MicroRNA in the ovary and female reproductive tract", J Anim Sci, 87, pp.29~38 (2009)
- Chin LJ, "A SNP in a let-7 microRNA complementary site in the KRAS 3′ untranslated region increases non-small cell lung cancer risk", Cancer Res, 68, pp.8535~8540 (2008)
- Christensen BC, "A let-7 micro RNA-binding site polymorphism in the KRAS 3′ UTR is associated with reduced survival in oral cancers", Carcinogenesis, 30, pp.1003~1007 (2009)
- Esquela-Kerscher A, "Oncomirs: microRNAs with a role in cancer", Nat Rev Cancer, 6, pp.259~269 (2006)
- Johnson SM, "RAS is regulated by the let-7 microRNA family", Cell, 120, pp.635~647 (2005)
- Martínez-Cruz B, "In the heartland of Eurasia: the multilocus genetic landscape of Central Asian populations", Eur J Hum Genet, 19, pp.216~223 (2011)
- Mishra PJ, "MicroRNA polymorphisms: the future of pharmacogenomics, molecular epidemiology and individualized medicine", Pharmacogenomics, 10, pp.399~416 (2009)
- Nelson HH, "KRAS mutation, KRAS-LCS6 polymorphism, and non-small cell lung cancer", Lung Cancer, 69, pp.51~53 (2010)
- Paranjape T, "A 3′-untranslated region KRAS variant and triplenegative breast cancer: a case-control and genetic analysis", Lancet Oncol, 12, pp.377~386 (2011)
- Paranjape T, "MicroRNAs: tools for cancer diagnostics", Gut, 58, pp.1546~1554 (2009)
- Peng MS, "Inland post-glacial dispersal in East Asia revealed by mitochondrial haplogroup M9a’b", BMC Biol, 9, pp.2~ (2011)
- Pharoah PD, "The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing", Clin Cancer Res, 17, pp.3742~3750 (2011)
- Ramon D, "Pyrosequencing trade mark: a one-step method for high resolution HLA typing", J Transl Med, 1(9), pp.2003~ (2003)
- Ratner E, "A KRAS-variant in ovarian cancer acts as a genetic marker of cancer risk", Cancer Res, 70, pp.6509~6515 (2010)
- Reddy SD, "MicroRNAs and cancer therapy: the next wave or here to stay?", Cancer Biol Ther, 9, pp.479~482 (2010)
- Ronaghi M, "A sequencing method based on real-time pyrophosphate", Science, 281, pp.365~ (1998)
- Schubbert S, "Hyperactive Ras in developmental disorders and cancer", Nat Rev Cancer, 7, pp.295~308 (2007)
- Sethupathy P, "MicroRNA target site polymorphisms and human disease", Trends Genet, 24, pp.489~497 (2008)
- Smits KM, "A let-7 microRNA SNP in the KRAS 3′ UTR is prognostic in early-stage colorectal cancer", Clin Cancer Res, 17, pp.7723~7731 (2011)
- Yang H, "Evaluation of genetic variants in microRNA-related genes and risk of bladder cancer", Cancer Res, 68, pp.2530~2537 (2008)
- Yoshiura K, "A SNP in the ABCC11 gene is the determinant of human earwax type", Nat Genet, 38, pp.324~330 (2006)